Home Medicine The natural course of Hashimoto’s thyroiditis in children and adolescents
Article
Licensed
Unlicensed Requires Authentication

The natural course of Hashimoto’s thyroiditis in children and adolescents

  • Hae Sang Lee and Jin Soon Hwang EMAIL logo
Published/Copyright: April 21, 2014

Abstract

Objective: Hashimoto’s thyroiditis (HT) is the most common cause of thyroid disease in children and adolescents, but little is known about the long-term follow-up of HT. The aim of this study was to analyze the clinical and laboratory characteristics and to observe the natural course of HT in children and adolescents.

Methods: We retrospectively reviewed 153 patients with HT diagnosed before 18 years of age. Subjects were grouped into euthyroid, subclinical hypothyroidism, overt hypothyroidism, and hyperthyroidism on the basis of the thyroid function test. Of the 153 subjects, 133 were followed up (range 6∼181 months) at our clinic every 6 months for evaluation of goiter size, thyroid function, thyroid peroxidase antibodies (TPO Ab), and thyroglobulin antibodies (TG Ab) serum concentration.

Results: Thyroid function tests at the time of presentation revealed euthyroid in 72 patients (47.1%), subclinical hypothyroidism in 48 (31.4%), overt hypothyroidism in 22 (14.4%), and hyperthyroidism in 11 (7.2%). Serum TPO Ab and TG Ab significantly decreased in the subclinical hypothyroidism group with levothyroxine treatment. Also, there was a significant decrease in the mean serum TG Ab levels among the overt hypothyroid patients during the follow-up period, although TPO Ab levels were not significantly different when compared to their baseline TPO Ab levels.

Conclusion: Most children with HT were euthryoid and remained euthyroid during follow-up. However, thyroid function should still be monitored periodically for early detection and treatment of overt hypothyroidism. Our data also showed that levothyroxine treatment may have beneficial effects on the thyroid antibody titers.


Corresponding author: Jin Soon Hwang, MD., Ph.D., Ajou University School of Medicine, Department of pediatrics, San 5, Wonchon-dong, Yeongtong-gu, Suwon, Korea, 443-721, Phone: +82-31-219-5166, Fax: +82-31-219-5169, E-mail:

References

1. Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto’s Thyroiditis. Pediatr Endocrinol Rev 2003;1(Suppl 2):205–11.Search in Google Scholar

2. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996;335:99–107.10.1056/NEJM199607113350206Search in Google Scholar PubMed

3. de Vries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child 2009;94:33–7.10.1136/adc.2007.134841Search in Google Scholar PubMed

4. Monzani A, Prodam F, Rapa A, Moia S, Agarla V, et al. Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol 2013;168:R1–R11.10.1530/EJE-12-0656Search in Google Scholar PubMed

5. Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, et al. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol (Oxf) 2012;76:394–8.10.1111/j.1365-2265.2011.04251.xSearch in Google Scholar PubMed

6. Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab 2006;91:1729–34.10.1210/jc.2005-2400Search in Google Scholar PubMed

7. Camurdan OM, Döğer E, Bideci A, Celik N, Cinaz P. Vitamin D status in children with Hashimoto thyroiditis. J Pediatr Endocrinol Metab 2012;25:467–70.10.1515/jpem-2012-0021Search in Google Scholar

8. Perez C, Scrimshaw NS, Munoz JA. Technique of endemic goitre surveys. Monogr Ser World Health Organ 1960;44: 369–83.Search in Google Scholar

9. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 2008;51:1–25.10.3345/kjp.2008.51.1.1Search in Google Scholar

10. Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A, et al. Hashimoto’s thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease. J Pediatr Endocrinol Metab 2007;20:1199–1205.10.1515/JPEM.2007.20.11.1199Search in Google Scholar

11. Wang SY, Tung YC, Tsai WY Lee JS, Hsiao PH. Long-term outcome of hormonal status in Taiwanese children with Hashimoto’s thyroiditis. Eur J Pediatr 2006;165:481–3.10.1007/s00431-006-0112-5Search in Google Scholar PubMed

12. Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, et al. The natural history of euthyroid Hashimoto’s thyroiditis in children. J Pediatr 2006;149:827–32.10.1016/j.jpeds.2006.08.045Search in Google Scholar PubMed

13. Gopalakrishnan S, Chugh PK, Chhillar M, Ambardar VK, Sahoo M, et al. Goitrous autoimmune thyroiditis in a pediatric population: a longitudinal study. Pediatrics 2008;122:e670–674.10.1542/peds.2008-0493Search in Google Scholar PubMed

14. Ozen S, Berk Ö, Şimsek DG, Darcan S. Clinical course of Hashimoto’s thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. J Clin Res Pediatr Endocrinol 2011;3:192–7.10.4274/jcrpe.425Search in Google Scholar PubMed PubMed Central

15. Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, et al. Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) treated with levothyroxine. Thyroid 2008;18:755–60.10.1089/thy.2008.0008Search in Google Scholar PubMed

16. Gartner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002;87:1687–91.10.1210/jcem.87.4.8421Search in Google Scholar PubMed

17. Duntas LH, Mantzou E, Koutras DA. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 2003;148:389–93.10.1530/eje.0.1480389Search in Google Scholar PubMed

18. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto’s thyroiditis. Thyroid 2007;17:609–12.10.1089/thy.2007.0040Search in Google Scholar PubMed

Received: 2013-9-17
Accepted: 2014-3-24
Published Online: 2014-4-21
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Downloaded on 6.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0373/html?lang=en
Scroll to top button